Istituto Nazionale Per le Malattie Infettive Lazzaro Spallanzani-Istituto di Ricovero e Cura A Carattere Scientifico

Istituto Nazionale Per le Malattie Infettive Lazzaro Spallanzani-Istituto di Ricovero e Cura A Carattere Scientifico is a research organisation in Roma, Italy that has taken part in 39 EU-funded projects since 2008, receiving €9.9M in EU funding.

EU funding received€9.9M
EU projects39
As coordinator0
Running now7
First EU project2008
Latest project2026
CountryItaly
EU registration (PIC)999471317
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Istituto Nazionale Per le Malattie Infettive Lazzaro Spallanzani-Istituto di Ricovero e Cura A Carattere Scientifico's own share of each project, not the project's full budget.

  • Horizon 2020€4.7M · 21 projects
  • FP7 (2007 to 2013)€1.9M · 4 projects
  • Horizon Europe€1.2M · 8 projects
  • 3rd Health Programme€1.2M · 5 projects
  • EU4Health Programme (EU4H)€876k · 1 project

Projects

39 EU-funded projects, newest first. Each links to the official record.

  • ISIDORe IIAssociated partner

    INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • EURL-PH-ERZVPartner

    EU reference laboratory consortium for emerging, rodent-borne and zoonotic viral pathogens

    EU4Health Programme (EU4H) · 2025–2031 · Project on the EU portal ↗

    €876ktheir share
  • EVORAAssociated partner

    European Viral Outbreak Response Alliance

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

  • INTERCEPTORPartner

    INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €39ktheir share
  • AVITHRAPIDPartner

    Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €572ktheir share
  • TBVAC-HORIZONPartner

    Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €350ktheir share
  • ISIDORePartner

    Integrated Services for Infectious Disease Outbreak Research

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €159ktheir share
  • EuCAREPartner

    European Cohorts of Patients and Schools to Advance Response to Epidemics

    Horizon Europe · 2021–2026 · Project on CORDIS ↗

    €70ktheir share
  • BY-COVIDAssociated partner

    Beyond COVID

    Horizon Europe · 2021–2024 · Project on CORDIS ↗

  • TTV GUIDE TXPartner

    PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €44ktheir share
  • JA TERRORPartner

    Joint Action TERROR: Strengthened Preparedness and Response to Biological and Chemical Terror Attacks.

    3rd Health Programme · 2021–2024 · Project on the EU portal ↗

    €341ktheir share
  • KRONOPartner

    Evaluation of a production ready portable, Point-of-Need Platform (instrument and reagents), direct from nasal swab test for the molecular diagnostic detection of COVID-19 infection.

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €246ktheir share
  • DECISIONPartner

    A minituarized disposable molecular diagnostics platform for combatting coronavirus infections

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €246ktheir share
  • EXSCALATE4CoVPartner

    EXaSCale smArt pLatform Against paThogEns for Corona Virus

    Horizon 2020 · 2020–2021 · Project on CORDIS ↗

    €116ktheir share
  • CoNVatPartner

    Combating 2019-nCoV: Advanced Nanobiosensing platforms for POC global diagnostics and surveillance

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €614ktheir share
  • EVA-GLOBALPartner

    European Virus Archive GLOBAL

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €145ktheir share
  • SHARP JAPartner

    Strengthened International HeAlth Regulations and Preparedness in the EU - Joint Action

    3rd Health Programme · 2019–2023 · Project on the EU portal ↗

    €414ktheir share
  • VHFMoDRADPartner

    Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €56ktheir share
  • ERINHA-AdvancePartner

    Advancing European Research Infrastcuture on Highly Pathogenic Agents

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

    €79ktheir share
  • ECRAID-PlanPartner

    European Clinical Research Alliance on Infectious Diseases (ECRAID) - Business Plan

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €71ktheir share
  • PITBULPartner

    Point-of-Care implementation of TB testing with ultra-fast Local Heating PCR

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €648ktheir share
  • COMBACTE-CDIPartner

    Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €150ktheir share
  • PEVIAPartner

    PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €274ktheir share
  • E-DETECT TBPartner

    EARLY DETECTION AND INTEGRATED MANAGEMENT OF TUBERCULOSIS IN EUROPE: E-DETECT TB

    3rd Health Programme · 2016–2020 · Project on the EU portal ↗

    €19ktheir share
  • EHVAPartner

    European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

    €250ktheir share
  • ERINHA2Partner

    European Research Infrastructure on Highly Pathogenic Agents 2

    Horizon 2020 · 2016–2017 · Project on CORDIS ↗

    €41ktheir share
  • HA-REACTPartner

    Joint Action on HIV and Co-infection Prevention and Harm Reduction

    3rd Health Programme · 2015–2019 · Project on the EU portal ↗

    €34ktheir share
  • EMERGEPartner

    Efficient response to highly dangerous and emerging pathogens at EU level

    3rd Health Programme · 2015–2019 · Project on the EU portal ↗

    €354ktheir share
  • EVAgPartner

    European Virus Archive goes global

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €314ktheir share
  • EbolaMoDRADPartner

    Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €309ktheir share
  • FILODIAGPartner

    Ultra-Fast Molecular Filovirus Diagnostics - Sofia ref.: 115844

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €404ktheir share
  • MofinaPartner

    Mobile Filovirus Nucleic Acid Test – Sofia ref.: 115848

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €218ktheir share
  • TBVAC2020Partner

    TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €218ktheir share
  • EVIDENTPartner

    Ebola Virus Disease - correlates of protection, determinants of outcome, and clinical management

    Horizon 2020 · 2014–2016 · Project on CORDIS ↗

    €226ktheir share
  • IF-EBOlaPartner

    Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy

    Horizon 2020 · 2014–2017 · Project on CORDIS ↗

    €53ktheir share
  • PREDEMICSPartner

    Preparedness, Prediction and Prevention of Emerging Zoonotic Viruses with Pandemic Potential using Multidisciplinary Approaches

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €752ktheir share
  • ERINHAPartner

    European Research Infrastructure on Highly Pathogenic Agents

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €249ktheir share
  • IDEAPartner

    Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €334ktheir share
  • APO-SYSPartner

    Apoptosis systems biology applied to cancer and AIDS. An integrated approach of experimental biology, data mining, mathematical modelling, biostatistics, systems engineering and molecular medicine

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €580ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA
  • antibiotic resistance
  • antibiotics
  • antivirals
  • artificial intelligence
  • business models
  • climatic changes
  • coronaviruses
  • crystallography
  • drug discovery
  • ebola
  • enzymes

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime